Evaluation framework for systems models.


Journal

CPT: pharmacometrics & systems pharmacology
ISSN: 2163-8306
Titre abrégé: CPT Pharmacometrics Syst Pharmacol
Pays: United States
ID NLM: 101580011

Informations de publication

Date de publication:
03 2022
Historique:
revised: 30 11 2021
received: 04 11 2019
accepted: 06 12 2021
pubmed: 19 12 2021
medline: 7 5 2022
entrez: 18 12 2021
Statut: ppublish

Résumé

As decisions in drug development increasingly rely on predictions from mechanistic systems models, assessing the predictive capability of such models is becoming more important. Several frameworks for the development of quantitative systems pharmacology (QSP) models have been proposed. In this paper, we add to this body of work with a framework that focuses on the appropriate use of qualitative and quantitative model evaluation methods. We provide details and references for those wishing to apply these methods, which include sensitivity and identifiability analyses, as well as concepts such as validation and uncertainty quantification. Many of these methods have been used successfully in other fields, but are not as common in QSP modeling. We illustrate how to apply these methods to evaluate QSP models, and propose methods to use in two case studies. We also share examples of misleading results when inappropriate analyses are used.

Identifiants

pubmed: 34921743
doi: 10.1002/psp4.12755
pmc: PMC8923730
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-289

Informations de copyright

© 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics.

Références

CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):69-79
pubmed: 27548289
CPT Pharmacometrics Syst Pharmacol. 2019 Apr;8(4):205-210
pubmed: 30697975
CPT Pharmacometrics Syst Pharmacol. 2021 Aug;10(8):804-825
pubmed: 34102034
Clin Pharmacol Ther. 1979 Oct;26(4):445-8
pubmed: 487692
Int J Numer Method Biomed Eng. 2014 May;30(5):525-44
pubmed: 24259465
Bull Math Biol. 2019 Sep;81(9):3425-3435
pubmed: 30693431
J Health Econ. 2003 Mar;22(2):151-85
pubmed: 12606142
CPT Pharmacometrics Syst Pharmacol. 2020 Mar;9(3):165-176
pubmed: 31957304
CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564
pubmed: 27647667
Bioinformatics. 2011 Sep 15;27(18):2610-1
pubmed: 21784792
CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):87-109
pubmed: 27884052
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):336-339
pubmed: 30924594
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1479-1484
pubmed: 34734497
Aging (Albany NY). 2010 Jun;2(6):361-8
pubmed: 20606248
CPT Pharmacometrics Syst Pharmacol. 2014 Feb 19;3:e101
pubmed: 24552986
CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):62-76
pubmed: 30417600
Comput Biol Med. 2010 Apr;40(4):402-7
pubmed: 20185123
AAPS J. 2020 Jul 17;22(5):93
pubmed: 32681207
CPT Pharmacometrics Syst Pharmacol. 2017 Aug;6(8):496-498
pubmed: 28585415
AAPS J. 2019 Jun 3;21(4):72
pubmed: 31161268
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
PLoS Comput Biol. 2018 Jan 19;14(1):e1005920
pubmed: 29351275
CPT Pharmacometrics Syst Pharmacol. 2016 May;5(5):235-49
pubmed: 27299936
Comput Methods Programs Biomed. 2007 Oct;88(1):52-61
pubmed: 17707944
AAPS J. 2017 Jul;19(4):1002-1016
pubmed: 28540623
Front Pharmacol. 2014 Nov 10;5:247
pubmed: 25426074
Sci Signal. 2009 Jun 30;2(77):ra31
pubmed: 19567914
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):340-343
pubmed: 30983158
CPT Pharmacometrics Syst Pharmacol. 2022 Mar;11(3):264-289
pubmed: 34921743
J Theor Biol. 2008 Sep 7;254(1):178-96
pubmed: 18572196
Physiol Rep. 2018 Mar;6(5):
pubmed: 29488355
Bioinformatics. 2009 Aug 1;25(15):1923-9
pubmed: 19505944
Environ Health Perspect. 1994 Dec;102 Suppl 11:37-50
pubmed: 7737040
CPT Pharmacometrics Syst Pharmacol. 2016 Mar;5(3):140-6
pubmed: 27069777
CPT Pharmacometrics Syst Pharmacol. 2015 Sep;4(9):547-57
pubmed: 26451334
Clin Pharmacol Ther. 2018 Nov;104(5):797
pubmed: 29943816
Syst Biol (Stevenage). 2005 Dec;152(4):214-20
pubmed: 16986263
J Theor Biol. 2018 Dec 7;458:31-46
pubmed: 30172689
Epidemics. 2018 Dec;25:89-100
pubmed: 29903539
NPJ Syst Biol Appl. 2017 Jan 05;3:16034
pubmed: 28725482
CPT Pharmacometrics Syst Pharmacol. 2020 Jan;9(1):21-28
pubmed: 31652029
Nature. 2019 Nov;575(7781):247-248
pubmed: 31690867
CPT Pharmacometrics Syst Pharmacol. 2016 Feb;5(2):43-53
pubmed: 26933515
Bioinformatics. 2003 Mar 1;19(4):524-31
pubmed: 12611808
CPT Pharmacometrics Syst Pharmacol. 2019 May;8(5):259-272
pubmed: 30667172
PLoS One. 2014 Oct 28;9(10):e110261
pubmed: 25350289
PLoS One. 2012;7(7):e40052
pubmed: 22815723

Auteurs

Sietse Braakman (S)

Application Engineering, MathWorks Inc, Natick, Massachusetts, USA.

Pras Pathmanathan (P)

Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

Helen Moore (H)

Laboratory for Systems Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH